ukmla MCQ (SBA): Osteoporosis Management (Bisphosphonate Intolerance)

Instant feedback + full explanation. One question, done properly.

MediumEndocrinologyOsteoporosis Management (Bisphosphonate Intolerance)ukmlamrcgp aktpaneprescribing safety assessment

A 78-year-old woman with known osteoporosis (T-score -3.0 at the hip) is taking alendronic acid 70mg once weekly. She complains of new-onset heartburn and difficulty swallowing pills. Which of the following is the most appropriate next step in her osteoporosis management?

Educational content. Not a substitute for clinical judgement or local policy.

ukmla MCQ: Osteoporosis Management (Bisphosphonate Intolerance) — Answ